Inventor
SAPRA PUJA
US16 patents
⚠️ This page may combine multiple inventors who share the name “SAPRA PUJA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PFIZER
7 patentsUS10617670B2Apr 14, 2020
Synergistic auristatin combinations
PFIZER25 citations87
US9777070B2Oct 3, 2017
Anti-PTK7 antibody-drug conjugates
PFIZER14 citations80
US9433687B2Sep 6, 2016
Anti-Notch3 antibodies and antibody-drug conjugates
PFIZER6 citations80
US9828428B2Nov 28, 2017
Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates
PFIZER2 citations71
US10689458B2Jun 23, 2020
Site specific HER2 antibody drug conjugates
PFIZER3 citations69
US9872922B2Jan 23, 2018
Anti-EFNA4 antibody-drug conjugates
PFIZER0 citations48
US9381205B2Jul 5, 2016
Anti-EFNA4 antibody-drug conjugates
PFIZER0 citations48
ENZON PHARMACEUTICALS INC
5 patentsUS7462627B2Dec 9, 2008
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
ENZON PHARMACEUTICALS INC13 citations90
US8048891B2Nov 1, 2011
Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
ENZON PHARMACEUTICALS INC5 citations73
US7671067B2Mar 2, 2010
Treatment of non-hodgkin's lymphomas with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamtothecin
ENZON PHARMACEUTICALS INC6 citations73
US7723351B2May 25, 2010
Multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin for treatment of breast, colorectal, pancreatic, ovarian and lung cancers
ENZON PHARMACEUTICALS INC7 citations71
US7928095B2Apr 19, 2011
Treatment of resistant or refractory cancers with multi-arm polymeric conjugates of 7-ethyl-10-hydroxycamptothecin
ENZON PHARMACEUTICALS INC5 citations62